Search Results - Veronika Bachanová

Refine Results
  1. 1
    NK Cells in Therapy of Cancer

    NK Cells in Therapy of Cancer by Veronika Bachanová, Jeffrey S. Miller

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Hodgkin Lymphoma in Pregnancy

    Hodgkin Lymphoma in Pregnancy by Veronika Bachanová, Joseph M. Connors

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Advances in NK cell therapy for hematologic malignancies: NK source, persistence and tumor targeting.

    Advances in NK cell therapy for hematologic malignancies: NK source, persistence and tumor targeting. by Aimee Merino, Joseph E. Maakaron, Veronika Bachanová

    Published 2023
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Clinical utility of natural killer cells in cancer therapy and transplantation

    Clinical utility of natural killer cells in cancer therapy and transplantation by David A. Knorr, Veronika Bachanová, Michael R. Verneris, Jeffrey S. Miller

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation

    Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation by Veronika Bachanová, Michael R. Verneris, Todd E. DeFor, Claudio G. Brunstein, Daniel J. Weisdorf

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Human Herpesvirus 6 is Associated with Status Epilepticus and Hyponatremia after Umbilical Cord Blood Transplantation

    Human Herpesvirus 6 is Associated with Status Epilepticus and Hyponatremia after Umbilical Cord Blood Transplantation by Fernanda Franceschi, Jaime Green, Zuzan Caycı, Evan Mariash, Mustapha A. Ezzeddine, Veronika Bachanová, Celalettin Üstün

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia

    Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia by Sean Tracy, Hrishi Venkatesh, Can Hekim, Lynn Heltemes-Harris, Todd P. Knutson, Veronika Bachanová, Michael A. Farrar

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells

    Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells by Xueqing Liang, E. Ashley Moseman, Michael A. Farrar, Veronika Bachanová, Daniel J. Weisdorf, Bruce R. Blazar, Wei Chen

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL

    Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL by Martin Felices, Behiye Kodal, Peter Hinderlie, Michał F. Kamiński, Sarah Cooley, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller, Veronika Bachanová

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NKG2A and LIR-1 Blockade

    Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NK... by Robert Godal, Veronika Bachanová, Michelle Gleason, Valarie McCullar, Gong Yun, Sarah Cooley, Michael R. Verneris, Philip B. McGlave, Jeffrey S. Miller

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Allogeneic natural killer cells for refractory lymphoma

    Allogeneic natural killer cells for refractory lymphoma by Veronika Bachanová, Linda J. Burns, David H. McKenna, Julie Curtsinger, Angela Panoskaltsis‐Mortari, Bruce R. Lindgren, Sarah Cooley, Daniel J. Weisdorf, Jeffrey S. Miller

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells

    Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells by Veronika Bachanová, Dhifaf Sarhan, Todd E. DeFor, Sarah Cooley, Angela Panoskaltsis‐Mortari, Bruce R. Blazar, Julie Curtsinger, Linda J. Burns, Daniel J. Weisdorf, Jeffrey S. Miller

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells

    Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells by Jiuxia Pang, Na Shen, Fei Yan, Na Zhao, Liping Dou, Lai‐Chu Wu, Christopher L. Seiler, Li Yu, Ke Yang, Veronika Bachanová, Eric Weaver, Natalia Tretyakova, Shujun Liu

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation

    Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation by Veronika Bachanová, Daniel J. Weisdorf, Tao Wang, Steven G. E. Marsh, Elizabeth Trachtenberg, Michael Haagenson, Stephen R. Spellman, Martha Ladner, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller, Sarah A. Cooley

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation by Susanta Hui, Claudio G. Brunstein, Yutaka Takahashi, Todd E. DeFor, Shernan G. Holtan, Veronika Bachanová, Christopher Wilke, Darren Zuro, Celalettin Üstün, Daniel J. Weisdorf, Kathryn E. Dusenbery, Michael R. Verneris

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network

    Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Mu... by Ginna G. Laport, Juan Wu, Brent R. Logan, Veronika Bachanová, Chitra Hosing, Timothy S. Fenske, Walter Longo, Steven M. Devine, Auayporn Nademanee, Iris D. Gersten, Mary M. Horowitz, Hillard M. Lazarus, Marcie Riches

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma

    Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma by Veronika Bachanová, Armin Ghobadi, Krish Patel, Jae H. Park, Ian W. Flinn, Prutha Shah, Carol Wong, Cara Bickers, Péter M. Szabó, Lilly Wong, Bahram Valamehr, Siminder Atwal, Yu‐Waye Chu, Rebecca Elstrom, Paolo Strati

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies

    Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies by Veronika Bachanová, Arthur E. Frankel, Qing Cao, Dixie Lewis, Bartosz Grzywacz, Michael R. Verneris, Celalettin Üstün, Aleksandr Lazaryan, Brian McClune, Erica D. Warlick, Hagop M. Kantarjian, Daniel J. Weisdorf, Jeffrey S. Miller, Daniel A. Vallera

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A Multicenter Retrospective Analysis of Clinical Outcomes, Toxicities, and Patterns of Use in Institutions Utilizing Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-Cell Lymphomas

    A Multicenter Retrospective Analysis of Clinical Outcomes, Toxicities, and Patterns of Use in Institutions Utilizing Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Rel... by Peter A. Riedell, Chase Walling, Loretta J. Nastoupil, Martina Pennisi, Richard T. Maziarz, Joseph P. McGuirk, Olalekan O. Oluwole, Veronika Bachanová, Wei‐Ting Hwang, Stephen J. Schuster, Miguel‐Angel Perales, Michael Bishop, David L. Porter

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

    First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia by Sarah Cooley, Fiona He, Veronika Bachanová, Gregory M. Vercellotti, Todd E. DeFor, Julie Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C. Conlon, Thomas A. Waldmann, David H. McKenna, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: